Talecris Biotherapeutics to Invest $268.7 Million to Expand its Manufacturing Facility in Clayton

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Talecris Biotherapeutics (Nasdaq: TLCR) and N.C. Gov. Bev Perdue jointly announced today that the company will expand its manufacturing facilities in Clayton, creating 259 new jobs over the next seven years. The company plans to spend $268.7 million to expand their facilities in Clayton. State and local tax credits and incentive grants will be provided to facilitate the expansion.

MORE ON THIS TOPIC